Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone

Overview[ - collapse ][ - ]

Purpose The purpose of this clinical research study is to learn whether Saxagliptin added to Metformin therapy is more effective than Metformin alone as a treatment for type 2 diabetic subjects who are not sufficiently controlled with Metformin alone
ConditionDiabetes Mellitus, Type 2
InterventionDrug: Saxagliptin + Metformin
Drug: Saxagliptin + Metformin
Drug: Saxagliptin + Metformin
Drug: Placebo + Metformin
Drug: Pioglitazone
PhasePhase 3
SponsorBristol-Myers Squibb
Responsible PartyBristol-Myers Squibb
ClinicalTrials.gov IdentifierNCT00121667
First ReceivedJuly 18, 2005
Last UpdatedAugust 5, 2011
Last verifiedAugust 2011

Tracking Information[ + expand ][ + ]

First Received DateJuly 18, 2005
Last Updated DateAugust 5, 2011
Start DateAugust 2005
Estimated Primary Completion DateFebruary 2010
Current Primary Outcome MeasuresBaseline and Change From Baseline in Hemoglobin A1c (A1C) at Week 24 [Time Frame: Baseline, Week 24] [Designated as safety issue: No]Mean change from baseline is adjusted for baseline value.
Current Secondary Outcome Measures
  • Baseline and Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24 [Time Frame: Baseline, Week 24] [Designated as safety issue: No]Mean change from baseline is adjusted for baseline value.
  • Percentage of Participants Achieving Therapeutic Glycemic Response (A1C < 7.0%) at Week 24 [Time Frame: Week 24] [Designated as safety issue: No]
  • Baseline and Change From Baseline at Week 24 in Postprandial Glucose (PPG) Area Under the Curve (AUC) [Time Frame: Baseline, Week 24] [Designated as safety issue: No]Mean change from baseline is adjusted for baseline value.

Descriptive Information[ + expand ][ + ]

Brief TitleStudy Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone
Official Title"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial to Evaluate the Efficacy and Safety of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone"
Brief Summary
The purpose of this clinical research study is to learn whether Saxagliptin added to
Metformin therapy is more effective than Metformin alone as a treatment for type 2 diabetic
subjects who are not sufficiently controlled with Metformin alone
Detailed Description
All subjects will participate in a lead-in period, and qualifying subjects will continue
into a short-term randomized treatment period. Subjects who complete the short-term period
will be eligible to enter the long term extension period. Also, subjects in the short-term
period who have an elevated blood sugar that requires additional medication for blood sugar
control will be eligible to enter the long-term treatment extension period where they will
receive pioglitizone added onto their blinded study medication
Study TypeInterventional
Study PhasePhase 3
Study DesignAllocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
ConditionDiabetes Mellitus, Type 2
InterventionDrug: Saxagliptin + Metformin
Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT)
Other Names:
BMS-477118Drug: Saxagliptin + Metformin
Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT)
Other Names:
BMS-477118Drug: Saxagliptin + Metformin
Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT)
Other Names:
BMS-477118Drug: Placebo + Metformin
Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT)
Drug: Pioglitazone
Tablets, Oral, 15 - 45 mg (as needed for rescue)
Study Arm (s)
  • Experimental: Saxagliptin + Metformin (A)
    Pioglitazone 15-45 mg (as needed for rescue)
  • Experimental: Saxagliptin + Metformin (B)
    Pioglitazone 15-45 mg (as needed for rescue)
  • Experimental: Saxagliptin + Metformin (C)
    Pioglitazone 15-45 mg (as needed for rescue)
  • Placebo Comparator: Placebo+ Metformin (D)
    Pioglitazone 15-45 mg (as needed for rescue)

Recruitment Information[ + expand ][ + ]

Recruitment StatusCompleted
Estimated Enrollment1462
Estimated Completion DateFebruary 2010
Estimated Primary Completion DateOctober 2006
Eligibility Criteria
Inclusion Criteria:

- Type 2 diabetes mellitus requiring treatment with at least 1500 mg but not greater
than 2550 mg of a maximum tolerated dose of Metformin therapy for at least 8 weeks
prior to screening.

- HbA1c >= 7.0% and <= 10.0 %

- Body mass index <= 40 kg/m2

- Fasting C-peptide >= 1 ng/dL

Exclusion Criteria:

- Symptomatic poorly controlled diabetes

- Recent cardiac or cerebrovascular event

- Serum creatinine >= 1.5 mg/dL for males and >= 1.4 mg/dL for females
GenderBoth
Ages18 Years
Accepts Healthy VolunteersNo
ContactsNot Provided
Location CountriesUnited States, Argentina, Australia, Brazil, Canada, Chile, Mexico, Puerto Rico, Taiwan

Administrative Information[ + expand ][ + ]

NCT Number NCT00121667
Other Study ID NumbersCV181-014
Has Data Monitoring CommitteeNot Provided
Information Provided ByBristol-Myers Squibb
Study SponsorBristol-Myers Squibb
CollaboratorsNot Provided
Investigators Not Provided
Verification DateAugust 2011

Locations[ + expand ][ + ]

Local Institution
Anniston, Alabama, United States
Local Institution
Birmingham, Alabama, United States
Local Institution
Calera, Alabama, United States
Local Institution
Haleyville, Alabama, United States
Local Institution
Mesa, Arizona, United States
Local Institution
Phoenix, Arizona, United States
Local Institution
Jonesboro, Arkansas, United States
Local Institution
Little Rock, Arkansas, United States
Local Institution
Sherwood, Arkansas, United States
Local Institution
Encino, California, United States
Local Institution
Fountain Valley, California, United States
Local Institution
Fresno, California, United States
Local Institution
Los Angeles, California, United States
Local Institution
Mission Viejo, California, United States
Local Institution
Northridge, California, United States
Local Institution
Orange, California, United States
Local Institution
Roseville, California, United States
Local Institution
Sacramento, California, United States
Local Institution
Spring Valley, California, United States
Local Institution
Tustin, California, United States
Local Institution
Castle Rock, Colorado, United States
Local Institution
Colorado Springs, Colorado, United States
Local Institution
Denver, Colorado, United States
Local Institution
Golden, Colorado, United States
Local Institution
Loveland, Colorado, United States
Local Institution
Altamonte Springs, Florida, United States
Local Institution
Chipley, Florida, United States
Local Institution
Cocoa Beach, Florida, United States
Local Institution
Coral Gables, Florida, United States
Local Institution
Fort Lauderdale, Florida, United States
Local Institution
Jacksonville, Florida, United States
Local Institution
Kissimmee, Florida, United States
Local Institution
Marianna, Florida, United States
Local Institution
Miami, Florida, United States
Local Institution
New Port Richey, Florida, United States
Local Institution
Ocala, Florida, United States
Local Institution
Tallahassee, Florida, United States
Local Institution
Tampa, Florida, United States
Local Institution
Decatur, Georgia, United States
Local Institution
Chicago, Illinois, United States
Local Institution
Vernon Hills, Illinois, United States
Local Institution
Elkhart, Indiana, United States
Local Institution
Lafayette, Indiana, United States
Local Institution
Iowa City, Iowa, United States
Local Institution
Waterloo, Iowa, United States
Local Institution
Topeka, Kansas, United States
Local Institution
Lexington, Kentucky, United States
Local Institution
Munfordville, Kentucky, United States
Local Institution
New Orleans, Louisiana, United States
Local Institution
West Monroe, Louisiana, United States
Local Institution
Baltimore, Maryland, United States
Local Institution
Chester, Maryland, United States
Local Institution
Prince Frederick, Maryland, United States
Local Institution
Boston, Massachusetts, United States
Local Institution
Kansas City, Missouri, United States
Local Institution
St. Louis, Missouri, United States
Local Institution
Kalispell, Montana, United States
Local Institution
Omaha, Nebraska, United States
Local Institution
Las Vegas, Nevada, United States
Local Institution
Toms River, New Jersey, United States
Local Institution
Albuquerque, New Mexico, United States
Local Institution
Charlotte, North Carolina, United States
Local Institution
Greensboro, North Carolina, United States
Local Institution
Morehead City, North Carolina, United States
Local Institution
Salisbury, North Carolina, United States
Local Institution
Sparta, North Carolina, United States
Local Institution
Wilmington, North Carolina, United States
Local Institution
Winston Salem, North Carolina, United States
Local Institution
Athens, Ohio, United States
Local Institution
Columbus, Ohio, United States
Local Institution
Lyndhurst, Ohio, United States
Local Institution
Oklahoma City, Oklahoma, United States
Local Institution
Tulsa, Oklahoma, United States
Local Institution
Eugene, Oregon, United States
Local Institution
Portland, Oregon, United States
Local Institution
Carlisle, Pennsylvania, United States
Local Institution
Langhorne, Pennsylvania, United States
Local Institution
Levittown, Pennsylvania, United States
Local Institution
Philadelphia, Pennsylvania, United States
Local Institution
Pittsburgh, Pennsylvania, United States
Local Institution
Charleston, South Carolina, United States
Local Institution
Duncan, South Carolina, United States
Local Institution
Bristol, Tennessee, United States
Local Institution
Austin, Texas, United States
Local Institution
Bryan, Texas, United States
Local Institution
Carrollton, Texas, United States
Local Institution
Dallas, Texas, United States
Local Institution
Houston, Texas, United States
Local Institution
San Antonio, Texas, United States
Local Institution
Temple, Texas, United States
Local Institution
Salt Lake City, Utah, United States
Local Institution
Hampton, Virginia, United States
Local Institution
Virginia Beach, Virginia, United States
Local Institution
Olympia, Washington, United States
Local Institution
Spokane, Washington, United States
Local Institution
Mar Del Plata, Buenos Aires, Argentina
Local Institution
Rosario, Santa Fe, Argentina
Local Institution
Buenos Aires, Argentina
Local Institution
Cordoba, Argentina
Local Institution
Sydney, New South Wales, Australia
Local Institution
Woollongong, New South Wales, Australia
Local Institution
Brisbane, Queensland, Australia
Local Institution
Kippa Ring, Queensland, Australia
Local Institution
Meadowbrook, Queensland, Australia
Local Institution
Adelaide, South Australia, Australia
Local Institution
Woodville South, South Australia, Australia
Local Institution
Perth, Western Australia, Australia
Local Institution
Fortaleza, Ceara, Brazil
Local Institution
Belem, Para, Brazil
Local Institution
Porto alegre, Rio Grande Do Sul, Brazil
Local Institution
Campinas, Sao Paulo, Brazil
Local Institution
Marilia, Sao Paulo, Brazil
Local Institution
Sao Paulo, Brazil
Local Institution
Calgary, Alberta, Canada
Local Institution
Coquitlam, British Columbia, Canada
Local Institution
Kelowna, British Columbia, Canada
Local Institution
Surrey, British Columbia, Canada
Local Institution
Brandon, Manitoba, Canada
Local Institution
Portage La Prairie, Manitoba, Canada
Local Institution
Winnipeg, Manitoba, Canada
Local Institution
Bathurst, New Brunswick, Canada
Local Institution
Mount Pearl, Newfoundland and Labrador, Canada
Local Institution
St. John's, Newfoundland and Labrador, Canada
Local Institution
St. Johns, Newfoundland and Labrador, Canada
Local Institution
Aylmer, Ontario, Canada
Local Institution
London, Ontario, Canada
Local Institution
Oakville, Ontario, Canada
Local Institution
Sarnia, Ontario, Canada
Local Institution
Thornhill, Ontario, Canada
Local Institution
Toronto, Ontario, Canada
Local Institution
Woodstock, Ontario, Canada
Local Institution
Charlottetown, Prince Edward Island, Canada
Local Institution
Drummondville, Quebec, Canada
Local Institution
Fleurimont, Quebec, Canada
Local Institution
Longueuil, Quebec, Canada
Local Institution
St. Leonard, Quebec, Canada
Local Institution
Saskatoon, Saskatchewan, Canada
Local Institution
Santiago, Metropolitana, Chile
Local Institution
Santiago De Chile, Metropolitana, Chile
Local Institution
Celaya, Guanajuato, Mexico
Local Institution
Guadalajara, Jalisco, Mexico
Local Institution
Morelia, Michioacan, Mexico
Local Institution
Monterrey, Nuevo Leon, Mexico
Local Institution
Hermosillo, Sonora, Mexico
Local Institution
Merida, Yucatan, Mexico
Local Institution
Distrito Federal, Mexico
Local Institution
Durango, Mexico
Local Institution
Carolina, Puerto Rico
Local Institution
Ponce, Puerto Rico
Local Institution
Rio Pieoras, Puerto Rico
Local Institution
San Juan, Puerto Rico
Local Institution
Hualien, Taiwan
Local Institution
Taichung, Taiwan
Local Institution
Taipei, Taiwan